Can-Fite BioPharma Ltd. Accumulated Other Comprehensive Income
Can-Fite BioPharma Ltd. (CANF) had Accumulated Other Comprehensive Income of $1.13 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-03-26
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.13M.
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.13M.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.13M.
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $1.13M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-12-31 | $1.13M 20-F · filed 2026-03-26 |
| 2025-06-30 | $1.13M 6-K · filed 2025-08-28 |
| 2024-12-31 | $1.13M 20-F · filed 2026-03-26 |
| 2024-06-30 | $1.13M 6-K · filed 2024-08-29 |
| 2023-12-31 | $1.13M 20-F · filed 2025-04-14 |
| 2023-06-30 | $1.13M 6-K · filed 2023-08-31 |
| 2022-12-31 | $1.13M 20-F · filed 2024-03-28 |
| 2022-06-30 | $1.13M 6-K · filed 2022-08-25 |
| 2021-12-31 | $1.13M 20-F · filed 2023-03-30 |
| 2021-06-30 | $1.13M 6-K · filed 2021-08-26 |
| 2020-12-31 | $1.13M 20-F · filed 2022-03-24 |
| 2020-06-30 | $1.13M 6-K · filed 2020-08-27 |
| 2019-12-31 | $1.13M 20-F · filed 2021-03-25 |
| 2018-12-31 | $1.13M 6-K · filed 2020-06-01 |